Skip to main content

Fibromyalgia/Pain

      👴🏼 Ageing & RMDs at #ACR24

      🧠 14 factors associated with dementia

      ❗️Justin Levenson tells us that if w
      1 month ago
      👴🏼 Ageing & RMDs at #ACR24 🧠 14 factors associated with dementia ❗️Justin Levenson tells us that if we could address all of these, we could reduce dementia risk by 45%! @RheumNow https://t.co/SgC5KMohXy
      Are you pts using cannabis?
      In Canada - 20% reported using w/in past 2 years
      Use for pain, sleep, anxiety
      78% noted effi
      1 month ago
      Are you pts using cannabis? In Canada - 20% reported using w/in past 2 years Use for pain, sleep, anxiety 78% noted efficacy Compare to another study said 57% stopped due to inefficacy, 28% AEs - very diff result 70% did not tell their doc 16S18 @BharatKumarMD #ACR24 @RheumNow https://t.co/6NAECW5MJK
      Cannabis and Physical Function
      Very small effects on meta-analysis

      PO cannabis - 4% benefit (0.1-8%) of achieving at le
      1 month ago
      Cannabis and Physical Function Very small effects on meta-analysis PO cannabis - 4% benefit (0.1-8%) of achieving at least MID of SF36 function scale 16S18 @BharatKumarMD #ACR24 @RheumNow https://t.co/qQOYt1m3ub
      Clauw: think of THC and CBD as “completely different”
      Cannabidiol - safe, not psychoactive, “can use liberally”
      1 month ago
      Clauw: think of THC and CBD as “completely different” Cannabidiol - safe, not psychoactive, “can use liberally” THC - psychoactive with effects on CB1 and CB2 receptors. CB1 affects the brain where CB2 is more in inflammation #ACR24 @RheumNow https://t.co/A0TgSpAO64
      Happening now:
      16S18 Into the Weeds: Cannabis in Rheum
      @EleniTiniakou @BharatKumarMD

      Do you discuss marijuana with you
      1 month ago
      Happening now: 16S18 Into the Weeds: Cannabis in Rheum @EleniTiniakou @BharatKumarMD Do you discuss marijuana with your patients? @RheumNow #ACR24
      #0582🔬Challenges in Achieving PsA Disease Control

      ➡️n=2,093; 18% and 8% achieved minimal, very low disease acti
      #0582🔬Challenges in Achieving PsA Disease Control ➡️n=2,093; 18% and 8% achieved minimal, very low disease activity respectively 🔑Higher QoL & monotherapy⬆️success; female sex, fatigue, spine pain⬇️outcomes. 🩺Unmet needs remain in PsA; tailored Rx needed #ACR24 @RheumNow
      Amazing review @NamrataRheum on the important role the rheumatologist can play to improve the care of our older patients
      Amazing review @NamrataRheum on the important role the rheumatologist can play to improve the care of our older patients! Don’t forget the 5Ms! 🧠Mind (cog/mood) 💊Medication (PIM) 🏃‍♀️Mobility 👉Multi-complexity 💪🏻Matters most (pt priority) @RheumNow #ACR24 #gerirheum https://t.co/0Iv4TdS8AX
      Myths by Daniel Clauw

      Small fiber neuropathy - misnomer, non-specific, not worth getting a skin biopsy

      Fibromyalgia is
      1 month ago
      Myths by Daniel Clauw Small fiber neuropathy - misnomer, non-specific, not worth getting a skin biopsy Fibromyalgia is not autoimmune - it is nociplastic pain and treated differently #ACR24 Review Course @RheumNow https://t.co/JLyfnfMBML
      Pain in PsA = predictor of disability and QoL

      TYK-2 inhibition lowered clinical pain outcomes and ALSO pain-associated
      Pain in PsA = predictor of disability and QoL TYK-2 inhibition lowered clinical pain outcomes and ALSO pain-associated biomarkers vs PBO @RheumNow #ACR24 Abstract #2366 https://t.co/DAgmdmmTE0
      ×